Evicenter
P&T meetings

Molgramostim Inhalation Solution

Autoimmune pulmonary alveolar proteinosis

Manufacturer
Savara
Regulatory submission
BLA resubmitted December 2025
Launch
Not announced
89 sources

Section 6 of 6

References

89 sources

  1. Akasaka et al. (2015) (opens in a new tab)
  2. Alfaro et al. (2025) (opens in a new tab)
  3. Alfaro et al. (2025) (opens in a new tab)
  4. Ataya et al. (2025a) (opens in a new tab)
  5. Ataya et al. (2025a) (opens in a new tab)
  6. Ataya et al. (2025b) (opens in a new tab)
  7. Bonella and Borie (2025a) (opens in a new tab)
  8. Bonella et al. (2025b) (opens in a new tab)
  9. Bonella et al. (2025c) (opens in a new tab)
  10. Campo et al. (2022) (opens in a new tab)
  11. Campo et al. (2024) (opens in a new tab)
  12. Carey et al. (2022) (opens in a new tab)
  13. CenterWatch (2026) (opens in a new tab)
  14. Chen et al. (2025a) (opens in a new tab)
  15. Chen et al. (2025b) (opens in a new tab)
  16. ClinicalTrials.gov NCT03482752 (opens in a new tab)
  17. ClinicalTrials.gov NCT04544293 (opens in a new tab)
  18. ClinicalTrials.gov NCT04544293 (opens in a new tab)
  19. ClinicalTrials.gov NCT06431776 (opens in a new tab)
  20. ClinicalTrials.gov NCT06546098 (opens in a new tab)
  21. CTIS.eu 2024-512039-66-00 (opens in a new tab)
  22. Dang et al. (2026) (opens in a new tab)
  23. European Respiratory Society (opens in a new tab)
  24. FDA Orphan Drug Designations and Approvals (2012) (opens in a new tab)
  25. Futami et al. (2026) (opens in a new tab)
  26. Gajewska et al. (2018) (opens in a new tab)
  27. Guirriec et al. (2024) (opens in a new tab)
  28. Higgins et al. (2026) (opens in a new tab)
  29. Inoue et al. (2008) (opens in a new tab)
  30. Inoue et al. (2008) (opens in a new tab)
  31. Inoue et al. (2026) (opens in a new tab)
  32. Jehn and Bonella (2023) (opens in a new tab)
  33. Jouneau et al. (2025) (opens in a new tab)
  34. Kavuru et al. (2011) (opens in a new tab)
  35. Kim et al. (2022) (opens in a new tab)
  36. Lee et al. (2025) (opens in a new tab)
  37. Lettieri et al. (2024) (opens in a new tab)
  38. Loyola Medicine (opens in a new tab)
  39. Luisetti et al. (2011) (opens in a new tab)
  40. Mabo et al. (2023) (opens in a new tab)
  41. McCarthy et al. (2018) (opens in a new tab)
  42. McCarthy et al. (2022) (opens in a new tab)
  43. McCarthy et al. (2025) (opens in a new tab)
  44. McCarthy et al. (2026a) (opens in a new tab)
  45. McCarthy et al. (2026b) (opens in a new tab)
  46. Montaño et al. (2025) (opens in a new tab)
  47. Munsif et al. (2023) (opens in a new tab)
  48. Naeem et al. (2026) (opens in a new tab)
  49. Narita et al. (2026) (opens in a new tab)
  50. National Health Care Institute Horizonscan Geneesmiddelen (2026) (opens in a new tab)
  51. Papiris et al. (2014) (opens in a new tab)
  52. Savara Inc. (opens in a new tab)
  53. Savara Inc. (opens in a new tab)
  54. Savara Inc. (opens in a new tab)
  55. Savara Inc. (opens in a new tab)
  56. Savara Inc. (opens in a new tab)
  57. Savara Inc. (opens in a new tab)
  58. Savara Inc. (opens in a new tab)
  59. Savara Inc. (opens in a new tab)
  60. Savara Inc. (2024) (opens in a new tab)
  61. Savara Inc. (2025) (opens in a new tab)
  62. Savara Inc. (2025) (opens in a new tab)
  63. Savara Inc. (2025) (opens in a new tab)
  64. Savara Inc. (2025) (opens in a new tab)
  65. Savara Inc. (2026) (opens in a new tab)
  66. Savara Inc. (2026) (opens in a new tab)
  67. Savara Inc. (2026) (opens in a new tab)
  68. Savara Inc. (2026) (opens in a new tab)
  69. Savara Inc. (2026) (opens in a new tab)
  70. Savara Inc. ERS presentation (2019) (opens in a new tab)
  71. Savara Inc. expanded access policy (opens in a new tab)
  72. Savara Inc. Form 10-K (2023) (opens in a new tab)
  73. Sheng et al. (2018) (opens in a new tab)
  74. Soyez et al. (2018) (opens in a new tab)
  75. Strong et al. (2025) (opens in a new tab)
  76. Tazawa et al. (2019) (opens in a new tab)
  77. Tian et al. (2020) (opens in a new tab)
  78. Trapnell (2024a) (opens in a new tab)
  79. Trapnell (2024a) (opens in a new tab)
  80. Trapnell et al. (2019) (opens in a new tab)
  81. Trapnell et al. (2020) (opens in a new tab)
  82. Trapnell et al. (2024b) (opens in a new tab)
  83. Trapnell et al. (2025a) (opens in a new tab)
  84. Trapnell et al. (2025b) (opens in a new tab)
  85. Trapnell et al. (2025b) (opens in a new tab)
  86. Trapnell et al. (2026) (opens in a new tab)
  87. Wang et al. (2025) (opens in a new tab)
  88. WHO Collaborating Centre for Drug Statistics Methodology (2026) (opens in a new tab)
  89. Xiong et al. (2026) (opens in a new tab)